1. Home
  2. DSS vs SNOA Comparison

DSS vs SNOA Comparison

Compare DSS & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • SNOA
  • Stock Information
  • Founded
  • DSS 1984
  • SNOA 1999
  • Country
  • DSS United States
  • SNOA United States
  • Employees
  • DSS N/A
  • SNOA N/A
  • Industry
  • DSS Containers/Packaging
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSS Consumer Discretionary
  • SNOA Health Care
  • Exchange
  • DSS Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • DSS 7.7M
  • SNOA 6.4M
  • IPO Year
  • DSS N/A
  • SNOA 2007
  • Fundamental
  • Price
  • DSS $0.84
  • SNOA $5.09
  • Analyst Decision
  • DSS
  • SNOA
  • Analyst Count
  • DSS 0
  • SNOA 0
  • Target Price
  • DSS N/A
  • SNOA N/A
  • AVG Volume (30 Days)
  • DSS 25.4K
  • SNOA 3.9M
  • Earning Date
  • DSS 08-14-2025
  • SNOA 08-07-2025
  • Dividend Yield
  • DSS N/A
  • SNOA N/A
  • EPS Growth
  • DSS N/A
  • SNOA N/A
  • EPS
  • DSS N/A
  • SNOA N/A
  • Revenue
  • DSS $21,252,000.00
  • SNOA $14,912,000.00
  • Revenue This Year
  • DSS N/A
  • SNOA $23.00
  • Revenue Next Year
  • DSS N/A
  • SNOA $24.59
  • P/E Ratio
  • DSS N/A
  • SNOA N/A
  • Revenue Growth
  • DSS 10.24
  • SNOA 17.43
  • 52 Week Low
  • DSS $0.72
  • SNOA $1.75
  • 52 Week High
  • DSS $1.50
  • SNOA $6.92
  • Technical
  • Relative Strength Index (RSI)
  • DSS 39.36
  • SNOA 74.25
  • Support Level
  • DSS $0.83
  • SNOA $4.61
  • Resistance Level
  • DSS $0.90
  • SNOA $5.60
  • Average True Range (ATR)
  • DSS 0.05
  • SNOA 0.47
  • MACD
  • DSS -0.01
  • SNOA 0.19
  • Stochastic Oscillator
  • DSS 15.58
  • SNOA 54.70

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: